Market
Boston Scientific reports positive Q2 results yet opts to trim 2026 outlook
Boston Scientific reported positive second-quarter financial results but reduced its 2026 outlook, citing planned global restructuring efforts. The company's earnings beat expectations, though the forward guidance cut reflects anticipated impacts from the reorganization program on future performance and operations.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network